Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Use For Manufacturing, Processing, Repackaging and Pharmaceutical Compounding
TRIUMPH-1 Phase 3 Trial Results Eli Lilly revealed the promising TRIUMPH-1 Phase 3 trial results in May 2026
Patients should not use a compounded drug if an approved drug is available to treat a patient. There are no approved generic versions of Wegovy or Ozempic
1 In 2025, an estimated 226,650 people will be diagnosed with lung cancer, which will account for approximately 11.1% of all new cancer cases
Description Retatrutide 10 mg is a triple-agonist research peptide developed by Eli Lilly that simultaneously activates the GLP-1, GIP, and glucagon receptors
Okada, Y
US$ 26.92
US$ 26.21
US$ 29.57
US$ 29.52
US$ 25.51
US$ 25.49
US$ 22.28
US$ 25.69
